Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, Carlo, Lee, Virginia M.-Y., Trojanowski, John Q.·2007·Nature Reviews Neuroscience

DOI 10.1038/nrn2194

Cited by (1,013)

Items 101–200 of 1,013

α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
Yanhui Zhang, Dawei Wang, Shuangfeng Xu, Shuai Zhang, Yonggang Fan, Yingying Yang, Shiqi Guo, Shan Wang, Tian Guo, Zhan‐You Wang et al. · 2017 · Redox Biology
MicroRNAs in Alzheimer’s Disease
Mengli Wang, Lixia Qin, Beisha Tang · 2019 · Frontiers in Genetics
Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant
Sydow, Astrid, Van der Jeugd, Ann, Zheng, Fang, Ahmed, Tariq, Balschun, Detlef, Petrova, Olga, Drexler, Dagmar, Zhou, Lepu, Rune, Gabriele, Mandelkow, Eckhard et al. · 2011 · The Journal of Neuroscience
Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies
Shinohara, Mitsuru, Tachibana, Masaya, Kanekiyo, Takahisa, Bu, Guojun · 2017 · Journal of Lipid Research
Autophagic degradation of tau in primary neurons and its enhancement by trehalose
Krüger, Ulrike, Wang, Yipeng, Kumar, Satish, Mandelkow, Eva-Maria · 2012 · Neurobiology of Aging
Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
Wan, Ying-Wooi, Al-Ouran, Rami, Mangleburg, Carl G., Perumal, Thanneer M., Lee, Tom V., Allison, Katherine, Swarup, Vivek, Funk, Cory C., Gaiteri, Chris, Allen, Mariet et al. · 2020 · Cell Reports
Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
Xu‐Qiao Chen, William Cary Mobley · 2019 · Frontiers in Neuroscience
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia
Helois E. Radford, Julie A. Moreno, Nicholas Verity, Mark Halliday, Giovanna R. Mallucci · 2015 · Acta Neuropathologica
Neuroimaging biomarkers for Alzheimer’s disease.
Márquez, Freddie, Yassa, Michael A. · 2019 · Molecular Neurodegeneration
High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Julien, Carl, Tremblay, Cyntia, Phivilay, Alix, Berthiaume, Line, Émond, Vincent, Julien, Pierre, Calon, Frédéric · 2010 · Neurobiology of Aging
Resting-State Brain Activity in Schizophrenia and Major Depression: A Quantitative Meta-Analysis
Simone Kühn, Juergen Gallinat · 2011 · Schizophrenia Bulletin
Development of tau aggregation inhibitors for alzheimer's disease
Bulic, Bruno, Pickhardt, Marcus, Schmidt, Boris, Mandelkow, Eva‐Maria, Waldmann, Herbert, Mandelkow, Eckhard · 2009 · Angewandte Chemie International Edition
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer’s disease models
van Eersel, Janet, Ke, Yazi D., Liu, Xin, Delerue, Fabien, Kril, Jillian J., Götz, Jürgen, Ittner, Lars M. · 2010 · Proceedings of the National Academy of Sciences
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Peter John Crouch, Lin Wai Hung, Paul Anthony Adlard, Mikhalina Cortés, Varsha Lal, Gulay Filiz, Keyla A. Perez, Milawaty Nurjono, Aphrodite Caragounis, Tai Du et al. · 2009 · Proceedings of the National Academy of Sciences
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease
Chen, Qing, Du, Yang, Zhang, Kai, Liang, Zeyu, Li, Jinquan, Yu, Hao, Ren, Rong, Feng, Jin, Jin, Zhiming, Li, Fangyuan et al. · 2018 · ACS Nano
Dendritic Tau in Alzheimer’s Disease
Ittner, Arne, Ittner, Lars M. · 2018 · Neuron
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
Castillo-Carranza, Diana L., Sengupta, Urmi, Guerrero-Muñoz, Marcos J., Lasagna-Reeves, Cristian A., Gerson, Julia E., Singh, Gurpreet, Estes, D. Mark, Barrett, Alan D. T., Dineley, Kelly T., Jackson, George R. et al. · 2014 · The Journal of Neuroscience
Role of tau protein in Alzheimer’s disease: The prime pathological player
Muralidar, Shibi, Ambi, Senthil Visaga, Sekaran, Saravanan, Thirumalai, Diraviyam, Palaniappan, Balamurugan · 2020 · International Journal of Biological Macromolecules
The Pericyte: A Forgotten Cell Type with Important Implications for A lzheimer's Disease?
Ethan A. Winkler, Abhay P. Sagare, Berislav V. Zloković · 2014 · Brain Pathology
Hydrogen sulfide is neuroprotective in Alzheimer’s disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation
Daniel Giovinazzo, Biljana N. Bursać, Juan I. Sbodio, Sumedha Nalluru, Thibaut Vignane, Adele M. Snowman, Lauren M. Albacarys, Thomas W. Sedlak, Roberta Torregrossa, Matthew Whiteman et al. · 2021 · Proceedings of the National Academy of Sciences
Tau Accumulation Causes Mitochondrial Distribution Deficits in Neurons in a Mouse Model of Tauopathy and in Human Alzheimer's Disease Brain
Katherine J. Kopeikina, George A. Carlson, Rose Pitstick, Adam E. Ludvigson, Alan Peters, Jennifer Irene Luebke, Robert M. Koffie, Matthew P. Frosch, Bradley T. Hyman, Tara L. Spires‐Jones · 2011 · American Journal Of Pathology
Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy
Piras, Antonio, Collin, Ludovic, Grüninger, Fiona, Graff, Caroline, Rönnbäck, Annica · 2016 · Acta Neuropathologica Communications
Neurobiology of Alzheimer′s disease
Edakkunni Mohandas, Rajmohan Velayudhan, B Raghunath · 2009 · Indian Journal of Psychiatry
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Ittner, Arne, Chua, Sook Wern, Bertz, Josefine, Volkerling, Alexander, van der Hoven, Julia, Gladbach, Amadeus, Przybyla, Magdalena, Bi, Mian, van Hummel, Annika, Stevens, Claire H. et al. · 2016 · Science
Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease
Otero-Garcia, Marcos, Mahajani, Sameehan U., Wakhloo, Debia, Tang, Weijing, Xue, Yue-Qiang, Morabito, Samuel, Pan, Jie, Oberhauser, Jane, Madira, Angela E., Shakouri, Tamara et al. · 2022 · Neuron
The ubiquitin‐proteasome system in Alzheimer's disease
Salvatore Oddo · 2008 · Journal of Cellular and Molecular Medicine
Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain
Zlokovic, Berislav V., Deane, Rashid, Sagare, Abhay P., Bell, Robert D., Winkler, Ethan A. · 2010 · Journal of Neurochemistry
Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims
Sandra Martín‐Peláez, María Isabel Covas, Montserrat Fitó, Anita Kušar, Igor Pravst · 2013 · Molecular Nutrition & Food Research
Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains
Susana Boluda, Michiyo Iba, Bin Zhang, Kevin M. Raible, Virginia M.‐Y. Lee, John Q. Trojanowski · 2014 · Acta Neuropathologica
The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease
Corrêa, Sônia A. L., Eales, Katherine L. · 2012 · Journal of Signal Transduction
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease
Kazuhiro Nakamura, Alex Greenwood, Lester I. Binder, Eileen H. Bigio, Sarah Denial, Linda K. Nicholson, Xiao Zhen Zhou, Kun Ping Lu · 2012 · Cell
Liquid–liquid phase separation of tau protein: The crucial role of electrostatic interactions
Solomiia Boyko, Xu Qi, Tien‐Hao Chen, Krystyna A. Surewicz, Witold K. Surewicz · 2019 · Journal of Biological Chemistry
Where, when, and in what form does sporadic Alzheimerʼs disease begin?
Heiko Braak, Kelly Del Tredici · 2012 · Current Opinion in Neurology
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bing Bai, David Vanderwall, Yuxin Li, Xusheng Wang, Suresh Poudel, Hong Wang, Kaushik Kumar Dey, Ping‐Chung Chen, Ka Yang, Junmin Peng · 2021 · Molecular Neurodegeneration
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., Zlokovic, B. V. · 2012 · Cold Spring Harbor Perspectives in Medicine
The role of the LRRK2 gene in Parkinsonism
Li, Jie-Qiong, Tan, Lan, Yu, Jin-Tai · 2014 · Molecular Neurodegeneration
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Chu, Ting-Ting, Gao, Na, Li, Qian-Qian, Chen, Pu-Guang, Yang, Xi-Fei, Chen, Yong-Xiang, Zhao, Yu-Fen, Li, Yan-Mei · 2016 · Cell Chemical Biology
P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
Takeuchi, Hiroki, Iba, Michiyo, Inoue, Haruhisa, Higuchi, Makoto, Takao, Keizo, Tsukita, Kayoko, Karatsu, Yoshiko, Iwamoto, Yumiko, Miyakawa, Tsuyoshi, Suhara, Tetsuya et al. · 2011 · PLoS ONE
Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells
Usenovic, Marija, Niroomand, Shahriar, Drolet, Robert E., Yao, Lihang, Gaspar, Renee C., Hatcher, Nathan G., Schachter, Joel, Renger, John J., Parmentier-Batteur, Sophie · 2015 · The Journal of Neuroscience
Neurosteroids as regulators of neuroinflammation
Canelif Yılmaz, Kanelina Karali, Georgia Fodelianaki, Achille Gravanis, Triantafyllos Chavakis, Ioannis Charalampopoulos, Vasileia Ismini Alexaki · 2019 · Frontiers in Neuroendocrinology
Tau oligomers and tau toxicity in neurodegenerative disease
Sarah Ward, Diana S. Himmelstein, Jody K. Lancia, Lester I. Binder · 2012 · Biochemical Society Transactions
Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
McInnes, Joseph, Wierda, Keimpe, Snellinx, An, Bounti, Laura, Wang, Yu-Chun, Stancu, Ilie-Cosmin, Apóstolo, Nuno, Gevaert, Kris, Dewachter, Ilse, Spires-Jones, Tara L. et al. · 2018 · Neuron
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
Thomas Cope, Timothy Rittman, Robin Jacob Borchert, Peter Simon Jones, Deniz Vatansever, Kieren S. J. Allinson, Luca Passamonti, Patricia Vázquez Rodríguez, William Richard Bevan-Jones, John Tiernan O'Brien et al. · 2017 · Brain
The Association of Tau With Mitochondrial Dysfunction in Alzheimer’s Disease
Cheng, Ying, Bai, Feng · 2018 · Frontiers in Neuroscience
Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease
Wang, Zhi-Hao, Xiang, Jie, Liu, Xia, Yu, Shan Ping, Manfredsson, Fredric P., Sandoval, Ivette M., Wu, Shengxi, Wang, Jian-Zhi, Ye, Keqiang · 2019 · Cell Reports
Drosophila melanogaster in the Study of Human Neurodegeneration
Frank Hirth · 2010 · CNS & Neurological Disorders - Drug Targets
Soluble forms of tau are toxic in Alzheimer's disease
Kopeikina, Katherine, Hyman, Bradley, Spires-Jones, Tara · 2012 · Translational Neuroscience
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Haythum Osama Tayeb, Hyun Duk Yang, Bruce Heimburger Price, Frank I. Tarazi · 2011 · Pharmacology & Therapeutics
PKC ε Activation Prevents Synaptic Loss, Aβ Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice
Jarin Hongpaisan, Miao‐Kun Sun, Daniel L. Alkon · 2011 · Journal of Neuroscience
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
Sangyun Jeong · 2017 · Molecules and Cells
On the nature of medial temporal lobe contributions to the constructive simulation of future events
Daniel L. Schacter, Donna Rose Addis · 2009 · Philosophical Transactions of the Royal Society B Biological Sciences
Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections
Iba, Michiyo, McBride, Jennifer D., Guo, Jing L., Zhang, Bin, Trojanowski, John Q., Lee, Virginia M.-Y. · 2015 · Acta Neuropathologica
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars Matthias Ittner, Thomas Fath, Yazi Diana Ke, Mian Bi, Janet van Eersel, Kong M. Li, Peter William Gunning, Jürgen Götz · 2008 · Proceedings of the National Academy of Sciences
Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration
Xiaoyu Li, Yatender Kumar, Hans Zempel, Eva‐Maria Mandelkow, Jacek Biernat, Eckhard Mandelkow · 2011 · The EMBO Journal
Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease
Colgan, N., Siow, B., O'Callaghan, J.M., Harrison, I.F., Wells, J.A., Holmes, H.E., Ismail, O., Richardson, S., Alexander, D.C., Collins, E.C. et al. · 2016 · NeuroImage
Biomarkers of Alzheimer's disease
Rebecca Craig‐Schapiro, Anne M. Fagan, David M. Holtzman · 2008 · Neurobiology of Disease
Small molecules as potent biphasic modulators of protein liquid-liquid phase separation
W. Michael Babinchak, Benjamin K. Dumm, Sarah Venus, Solomiia Boyko, Andrea A. Putnam, Eckhard Jankowsky, Witold K. Surewicz · 2020 · Nature Communications
Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice
Peeraer, Eve, Bottelbergs, Astrid, Van Kolen, Kristof, Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Mahieu, Michel, Duytschaever, Hilde, Ver Donck, Luc, Torremans, An, Sluydts, Ellen et al. · 2015 · Neurobiology of Disease
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
Wingo, Aliza P., Dammer, Eric B., Breen, Michael S., Logsdon, Benjamin A., Duong, Duc M., Troncosco, Juan C., Thambisetty, Madhav, Beach, Thomas G., Serrano, Geidy E., Reiman, Eric M. et al. · 2019 · Nature Communications
Inflammation in the early stages of neurodegenerative pathology
Preeti J. Khandelwal, Alexander M. Herman, Charbel Moussa · 2011 · Journal of Neuroimmunology
Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11
Henry Houlden, Janel O. Johnson, Christopher Gardner‐Thorpe, Tammaryn Lashley, Dena G. Hernandez, Paul F. Worth, Andrew Singleton, David A. Hilton, Janice L. Holton, Tamás Révész et al. · 2007 · Nature Genetics
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
Govindpani, Karan, Calvo-Flores Guzmán, Beatriz, Vinnakota, Chitra, Waldvogel, Henry, Faull, Richard, Kwakowsky, Andrea · 2017 · International Journal of Molecular Sciences
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Natalia Louneva, Julia Wanda Cohen, Liying Han, Konrad Talbot, Robert S. Wilson, David Alan Bennett, John Q. Trojanowski, Steven Edward Arnold · 2008 · American Journal Of Pathology
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
Luca Passamonti, Patricia Vázquez Rodríguez, Young T. Hong, Kieren S. J. Allinson, David Williamson, Robin Jacob Borchert, Saber A. K. Sami, Thomas Cope, William Richard Bevan-Jones, Peter Simon Jones et al. · 2016 · Brain
Noncoding RNAs in Alzheimer's disease
Maria Laura Idda, Rachel B. Munk, Kotb Abdelmohsen, Myriam Gorospe · 2018 · Wiley Interdisciplinary Reviews - RNA
Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex
Philipp A. Jaeger, Fiona Pickford, Chung-Huan Johnny Sun, Kurt M. Lucin, Eliezer Masliah, Tony Wyss‐Coray · 2010 · PLoS ONE
Metal ions, Alzheimer's disease and chelation therapy
Budimir, Ana · 2011 · Acta Pharmaceutica
Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
Regan, Philip, Piers, Thomas, Yi, Jee-Hyun, Kim, Dong-Hyun, Huh, Seonghoo, Park, Se Jin, Ryu, Jong Hoon, Whitcomb, Daniel J., Cho, Kwangwook · 2015 · The Journal of Neuroscience
Epigenetic mechanisms in neurological and neurodegenerative diseases
Jorge Landgrave-Gómez, Octavio Fabián Mercado-Gómez, Rosalinda Guevara‐Guzmán · 2015 · Frontiers in Cellular Neuroscience
Tau phosphorylation affects its axonal transport and degradation
Teresa Rodríguez-Martín, Inmaculada Cuchillo‐Ibáñez, Wendy J. Noble, Fanon Nyenya, Brian H. Anderton, Diane P. Hanger · 2013 · Neurobiology of Aging
The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies
Diana A.T. Nijholt, Elise S. van Haastert, Annemieke J.M. Rozemüller, Wiep Scheper, Jeroen J.M. Hoozemans · 2011 · The Journal of Pathology
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease
Stutzbach, Lauren D, Xie, Sharon X, Naj, Adam C, Albin, Roger, Gilman, Sid, PSP Genetics Study Group, Lee, Virginia M Y, Trojanowski, John Q, Devlin, Bernie, Schellenberg, Gerard D · 2013 · Acta Neuropathologica Communications
Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau
Wenkai Li, Jeffrey B. Sperry, Alex Crowe, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee · 2009 · Journal of Neurochemistry
Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies
Carlo Ballatore, Kurt R. Brunden, Donna M. Huryn, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith · 2012 · Journal of Medicinal Chemistry
Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats
Lucian Hriţcu, Oana Cioancă, Monica Hăncianu · 2012 · Phytomedicine
Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity
Chronis Fatouros, Ghulam Jeelani Pir, Jacek Biernat, Sandhya Padmanabhan Koushika, Eckhard Mandelkow�, Eva‐Maria Mandelkow, Enrico Schmidt, Ralf Baumeister · 2012 · Human Molecular Genetics
Merging pathology with biomechanics using CHIMERA (Closed-Head Impact Model of Engineered Rotational Acceleration): a novel, surgery-free model of traumatic brain injury
Namjoshi, Dhananjay R, Cheng, Wai Hang, McInnes, Kurt A, Martens, Kris M, Carr, Michael, Wilkinson, Anna, Fan, Jianjia, Robert, Jerome, Hayat, Arooj, Cripton, Peter A et al. · 2014 · Molecular Neurodegeneration
Regulation of human MAPT gene expression
Marie‐Laure Caillet‐Boudin, Luc Buée, Nicolas Sergeant, Bruno Lefebvre · 2015 · Molecular Neurodegeneration
Formulations of Curcumin Nanoparticles for Brain Diseases
Del Prado-Audelo, María L., Caballero-Florán, Isaac H., Meza-Toledo, Jorge A., Mendoza-Muñoz, Néstor, González-Torres, Maykel, Florán, Benjamín, Cortés, Hernán, Leyva-Gómez, Gerardo · 2019 · Biomolecules
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
Yang Liu, Sai An, Jianfeng Li, Yuyang Kuang, Xi He, Yubo Guo, Haojun Ma, Yu Zhang, Bin Ji, Chen Jiang · 2015 · Biomaterials
Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease
Zalocusky, Kelly A., Najm, Ramsey, Taubes, Alice L., Hao, Yanxia, Yoon, Seo Yeon, Koutsodendris, Nicole, Nelson, Maxine R., Rao, Antara, Bennett, David A., Bant, Jason et al. · 2021 · Nature Neuroscience
The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle
Hans-Jörg Warnatz, Dominic Schmidt, Thomas Manke, Ilaria Piccini, Marc Sultan, Tatiana A. Borodina, Daniela Balzereit, Wasco Wruck, А. В. Солдатов, Martin Vingron et al. · 2011 · Journal of Biological Chemistry
Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Yazi Diana Ke, Fabien Delerue, Amadeus Gladbach, Jürgen Götz, Lars Matthias Ittner · 2009 · PLoS ONE
Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322
Zhongying Mo, Ying-Zhu Zhu, Haili Zhu, Jun-Bao Fan, Jie Chen, Yi Liang · 2009 · Journal of Biological Chemistry
Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia
Francesco Paonessa, Lewis Evans, Ravi Solanki, Delphine Larrieu, Selina Wray, John Hardy, Stephen P. Jackson, Frederick J. Livesey · 2019 · Cell Reports
Caspase-2 cleavage of tau reversibly impairs memory
Zhao, Xiaohui, Kotilinek, Linda A, Smith, Benjamin, Hlynialuk, Chris, Zahs, Kathleen, Ramsden, Martin, Cleary, James, Ashe, Karen H · 2016 · Nature Medicine
Axonal Transport RatesIn VivoAre Unaffected by Tau Deletion or Overexpression in Mice
Aidong Yuan, Asok R. Kumar, Corrinne M. Peterhoff, Karen Duff, Ralph A. Nixon · 2008 · Journal of Neuroscience
Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
Rocher, A.B., Crimins, J.L., Amatrudo, J.M., Kinson, M.S., Todd-Brown, M.A., Lewis, J., Luebke, J.I. · 2010 · Experimental Neurology
Membrane Trafficking Pathways in Alzheimer 's Disease
Lawrence Rajendran, Wim G. Annaert · 2012 · Traffic
β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease
Amantha Thathiah, Katrien Horré, An Snellinx, Elke Vandewyer, Yunhong Huang, Marta Ciesielska, Gerdien E. de Kloe, Sebastian Munck, Bart De Strooper · 2012 · Nature Medicine
Mentalizing under Uncertainty: Dissociated Neural Responses to Ambiguous and Unambiguous Mental State Inferences
Jenkins, A. C., Mitchell, J. P. · 2010 · Cerebral Cortex
AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure
Claire Thornton, Nicola J. Bright, Magdalena Sastre, Phillip J. Muckett, David Carling · 2011 · Biochemical Journal
Task-dependent organization of brain regions active during rest
Uri Hasson, Howard C. Nusbaum, Steven L. Small · 2009 · Proceedings of the National Academy of Sciences
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles
Francesc Xavier Guix, Grant T. Corbett, Diana Cha, Maja Mustapić, Wen Liu, David Mengel, Zhicheng Chen, Elena Aïkawa, Tracy L. Young‐Pearse, Dimitrios Kapogiannis et al. · 2018 · International Journal of Molecular Sciences
Amyloid assembly and disassembly
Edward Chuang, Acacia M Hori, Christina D. Hesketh, James Shorter · 2018 · Journal of Cell Science
Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
Urmi Sengupta, Marcos Jair Guerrero‐Munoz, Diana Laura Castillo‐Carranza, Cristian A. Lasagna‐Reeves, Julia E. Gerson, Adriana A. Paulucci-Holthauzen, Shashirekha Krishnamurthy, Malika Farhed, George R. Jackson, Rakez Kayed · 2015 · Biological Psychiatry
Tau protein and tau aggregation inhibitors
Bruno Bulic, Marcus Pickhardt, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2010 · Neuropharmacology
Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
Jianhua Shi, Tianyi Zhang, Chunlei Zhou, Muhammad Omar Chohan, Xiaosong Gu, Jerzy Węgiel, Jianhua Zhou, Yu‐Wen Hwang, Khalid Iqbal, Inge Grundke et al. · 2008 · Journal of Biological Chemistry
Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.
Kitazawa, Masashi, Medeiros, Rodrigo, M. LaFerla, Frank · 2012 · Current Pharmaceutical Design
Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
Jong‐Chan Park, Sun-Ho Han, Dahyun Yi, Min Soo Byun, Jun Ho Lee, Sukjin S. Jang, Kang Ko, So Yeon Jeon, Yun‐Sang Lee, Yu Kyeong Kim et al. · 2018 · Brain